Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Capital Work in Progress

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹3,266 Cr₹2,739 Cr₹4,496 Cr₹2,938 Cr₹2,429 Cr

What is the latest Capital Work in Progress ratio of AUROBINDO PHARMA ?

The latest Capital Work in Progress ratio of AUROBINDO PHARMA is ₹3,266 Cr based on Mar2025 Consolidated results.
Year Capital Work in Progress
Mar2025₹3,266 Cr
Mar2024₹2,739 Cr
Mar2023₹4,496 Cr
Mar2022₹2,938 Cr
Mar2021₹2,429 Cr

How is Capital Work in Progress of AUROBINDO PHARMA Trending?

Years Capital Work in Progress % Change
Mar2025 ₹3,266 Cr
19.22
Mar2024 ₹2,739 Cr
-39.08
Mar2023 ₹4,496 Cr
53.07
Mar2022 ₹2,938 Cr
20.94
Mar2021 ₹2,429 Cr -

Compare Capital Work in Progress of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹63,574.4 Cr 5.2% 3.5% -26.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹387,792.0 Cr 2.3% -0.4% -12.4% Stock Analytics
DIVIS LABORATORIES ₹159,986.0 Cr 0% 1.1% 10.7% Stock Analytics
CIPLA ₹127,124.0 Cr 2.1% 3.5% -4.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,700.0 Cr -1.2% -1.7% 4.5% Stock Analytics
DR REDDYS LABORATORIES ₹109,868.0 Cr 5.3% 7.9% -2% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

5.2%

3.5%

-26.9%

SENSEX

1.5%

1.6%

0.4%


You may also like the below Video Courses